GlassScriptPhysician profile
Jason Beland
NPI 1831122761
$1,699.32
in general payments reported to CMS, 2019-2025
27 companies · $62.58 in 2025
The $62.58 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $165 · 2021: $277 · 2022: $130 · 2023: $228 · 2024: $54.63 · 2025: $62.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $299.88 | 2020-2025 | Biograph Vision 600 (8 Ring/64 Ct), Somatom X.Cite, Oncozene |
| Astrazeneca Pharmaceuticals LP | $215.24 | 2019-2021 | |
| Sirtex Medical INC | $150.14 | 2019-2024 | Sir-Spheres Microspheres |
| Novartis Pharmaceuticals Corporation | $134.92 | 2019-2020 | |
| Advanced Accelerator Applications | $125.23 | 2019 | |
| Exelixis INC. | $125.00 | 2021 | |
| Amgen INC. | $83.93 | 2019 | |
| Merck Sharp & Dohme LLC | $62.97 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $59.09 | 2019-2021 | |
| Taiho Oncology, INC. | $45.86 | 2019 | |
| Galvanize Therapeutics, INC | $45.26 | 2023 | Aliya System |
| Ge Healthcare | $40.27 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.90 | 2019-2020 | |
| Healthmyne, INC. | $35.45 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.04 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $25.35 | 2022 | |
| Philips North America LLC | $24.93 | 2022 | |
| Eisai INC. | $24.44 | 2019-2020 | |
| Hologic Sales and Service, LLC | $19.05 | 2023 | Sertera Biopsy Device |
| Janssen Biotech, INC. | $15.98 | 2019 | |
| Allergan, INC. | $15.42 | 2020 | |
| Novocure INC. | $14.37 | 2019 | |
| Lilly USA, LLC | $14.11 | 2019 | |
| Daiichi Sankyo INC. | $13.02 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $12.58 | 2019 | |
| Celgene Corporation | $11.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Beland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.